Mineralys Therapeutics
MLYS
MLYS
222 hedge funds and large institutions have $3.21B invested in Mineralys Therapeutics in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 82 increasing their positions, 72 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7.99% less ownership
Funds ownership: 119.67% → 111.68% (-8%)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
45% less call options, than puts
Call options by funds: $114M | Put options by funds: $207M
Holders
222
Holding in Top 10
12
Calls
$114M
Puts
$207M
Top Buyers
| 1 | +$120M | |
| 2 | +$75.5M | |
| 3 | +$52.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$52.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$47.9M |
Top Sellers
| 1 | -$66.9M | |
| 2 | -$49.3M | |
| 3 | -$40.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$34.1M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$30.1M |
